EXACT Sciences Corporation Cash Flow Reinvestment Rate
EXACT Sciences Corporation cash flow reinvestment rate. EXACT Sciences Corporation (EXAS) has a Cash Flow Reinvestment Rate of 1.51x as of December 2025, reinvesting $228.60 Million (capex $31.24 Million plus investments $197.36 Million) from operating cash flow of $151.69 Million. See EXAS FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of EXACT Sciences Corporation (2020–2025)
Cash flow reinvestment rate of EXACT Sciences Corporation from 2020 to 2025. Historical reinvestment intensity for EXACT Sciences Corporation across 4 annual periods. Explore EXAS cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
EXACT Sciences Corporation Cash Flow Reinvestment Rate by Year (2020–2025)
EXACT Sciences Corporation cash flow reinvestment rate by year from 2020 to 2025. Year-by-year capital reinvestment analysis for EXACT Sciences Corporation. For the full cash flow conversion analysis, see cash flow conversion of EXACT Sciences Corporation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.04x | $511.17 Million | $491.44 Million | $134.66 Million | ▼ -62.1% |
| 2024 | 2.75x | $578.14 Million | $210.54 Million | $135.99 Million | ▲ +146.6% |
| 2023 | 1.11x | $173.87 Million | $156.12 Million | $124.19 Million | ▼ -46.4% |
| 2020 | 2.08x | $283.58 Million | $136.48 Million | $64.35 Million | — |